Short- and Long-Term Outcomes after Large Pulmonary Resection for Germ Cell Tumors After Bleomycin-Combination Chemotherapy Rafael S. Andrade, MD, Kenneth A. Kesler, MD, Jamison L. Wilson, MS, Jo Ann Brooks, DNS, Brett D. Reichwage, MS, Karen M. Rieger, MD, Lawrence H. Einhorn, MD, John W. Brown, MD The Annals of Thoracic Surgery Volume 78, Issue 4, Pages 1224-1228 (October 2004) DOI: 10.1016/j.athoracsur.2004.03.081
Fig 1 Long-term overall survival for patients who underwent large pulmonary resection. Curves depict long-term survival of the overall series (n = 28) and by postchemotherapy disease, benign (n = 13) versus malignant (n = 15). Numbers represent patients at risk at the 20-, 40-, and 60-month intervals for each group. The Annals of Thoracic Surgery 2004 78, 1224-1228DOI: (10.1016/j.athoracsur.2004.03.081)